We have a global team of experienced veterinarians that have now treated many thousands of cases. Please feel free to contact us to answer any questions on case selection and management, or the clinical application of Arthramid® Vet.
Method Of Administration
Arthramid® Vet is for intra-articular use only and must be administered by a qualified veterinarian familiar with the procedure in the intended species.
Animals may be sedated to minimise stress and discomfort. Strict aseptic conditions must be followed at all times.
A 20G to
Post Injection Instructions
An ointment can be applied to the injection site immediately after treatment. A cold pack can be used on the injection site in case of any oedema. A bandage can be applied around the injection site if possible. Local or systemic corticosteroids should not be administered to the animal within two weeks of injection of Arthramid® Vet since this may mask a possible infection. The animal should be rested for 48 hours after the treatment.
Some animals (< 1: 1000) may develop pain within the first postoperative hours. In addition, there is also a slight risk of haematoma and mild oedema. Within 1-2 weeks after treatment, there is a small risk that the animal may develop transient oedema and tenderness at the treatment site as the tissue integration is occurring. If not caused by infection, these reactions are self-limiting and will resolve within a couple of weeks. Non-steroidal anti-inflammatory drugs (NSAIDs) can be administered for pain relief and to reduce swelling. Joint lavage to remove non-integrated hydrogel can be considered in severe cases. Allergic reactions to Arthramid® Vet have never been observed.
As with any intra-articular procedure, an Arthramid® Vet injection carries a risk of infection. Standard precautions and strict aseptic injection technique is essential. In the event of infection, the use of broad spectra antibiotics is recommended as a first-line treatment. Any use of corticosteroids is contraindicated in case of infection.
Dosage - Equine
Due to Arthramid® Vets’ unique mode of action, the following dosage recommendations have been made based on observed clinical responses to treatment.
- Distal Interphalangeal (DIP/ Coffin) 1 mls
- Metacarpo/tarso-phalangeal (Fetlock) 1-2 mls
- Carpus- 1-2mls
- Tarso-metatarsal (TMT)/ Distal-intertarsal (DIT)- 1 ml
- Tarsocrural- 2-3 mls
- Shoulder- 2-3 mls
- Stifles- 1-2 ml per compartment e.g 1- 2mls for medial-femorotibial joint.
There is evidence to suggest that a dose-dependant response does exist and that these doses can be altered depending on the severity or chronicity of the disease. For example; mild, moderate or severe Fetlock disease can be treated with either 1ml, 2mls, or 3mls respectively.
It is always important to reassess cases 4-6 weeks after
Safety Studies indicate that concurrent treatment of multiple joints in the same animal is safe.
32 Hill Road, Cambridge, NZ Phone +64 (09) 8013 253 firstname.lastname@example.org
Interested in talking to us and learning more?
Arthramid Vet New Zealand
Registered in New Zealand to: Innovative Medical Solutions Limited NZBN: 9429041325544, 32 Hill Road, Cambridge 3494, New Zealand. Registered pursuant to the ACVM Act 1997 Number A11596. See www.foodsafety.govt.nz for registration conditions.
For use only by a veterinarian. Ask your vet to contact us today.